Aller au contenu Aller au menu principal Aller à la recherche

Our formulas: natural, healthy and no frills

Our formulas

We know that you value the composition of the health products you use. This is why it is our duty and our responsibility to select only quality ingredients to formulate natural, healthy and no-frills solutions. This ambition is embodied in a concept: « green galenic formulation ».

How are our products formulated?

Arkopharma's « green galenic formulation »: what is it?

« The green galenic formulation is a concept that combines both the formulation of health products and the exclusive use of ingredients of natural origin. »
Chantal Hombourger, Galenic Development Director at Arkopharma Laboratories

Galenics is the science and art of preparing an active ingredient to make it administrable in a suitable and easy-to-use form: capsules, tablets, drinkable ampoules, etc.

A galenic form is obtained by mixing with the active ingredients, raw materials to aid the formulation, called « excipients » or « additives » which will make it possible to obtain the desired form and guarantee its stability.

Since the creation of Arkopharma, we have sought to formulate our products using active ingredients of natural origin, mainly derived from plants. These assets are contained in the totum of the plant, that is to say all the components of the plant which act synergistically

To formulate a product, we add to the active ingredients raw materials that allow us to obtain the final properties.

To stay true to our values, we have chosen not to use chemical additives, nanoparticles or synthetic dyes.

Thus, today, all of our formulations use only natural materials, absolutely and strictly necessary to obtain the chosen galenic form.

Arkopharma's « green galenic formulation »: patented work

We test hundreds of raw materials every year, such as apple, oat, buckwheat, banana flour, etc. to replace any synthetic material in our formulas.




Oat fibre


Banana flour


Thanks to the work of our researchers, we have thus discovered that these raw materials inherently possess technological properties which, when mixed with our active ingredients, can confer technical properties on the product, allowing their final shaping. This work was patented in July 2018.

In order to guarantee the stability of these formulations, we have also developed methods of predictive stability, thus making it possible to offer our consumers safe, effective and natural products, until their expiration.

Appropriate galenic solutions

The galenic expertise of Arkopharma Laboratories is based on its capacity for innovation.

The galenic service identifies potentially interesting active ingredients, recently launched on the international market and having been the subject of serious studies, but also excipients.

It is this knowledge of the active ingredient / excipient pair that allows the galenic to fulfill its mission: to facilitate the use and consumption of original food supplements, in which the activity and effectiveness of the ingredients are preserved

The galenic department must also resolve other issues, in particular those of flavour in liquid forms. Plants are often characterized by a natural bitterness, the impact of which is all the more important when they are in liquid and drinkable forms. The role of the galenic service will then be either to look for plants with an acceptable flavour for a given indication, or to mask it.

The formulation of our products in a few figure

Total allergens

Allergènes totaux

93.2% of our raw materials used in food supplements are Allergen FREE.



98.7% of our raw materials used in food supplements do not contain Gluten.



98.5% of our raw materials used in food supplements do not contain Lactose.




100% of our formulas are Aspartame free.



85% of the food supplements developed in 2019 are Vegan.

Pork gelatin

Pork gelatin

99% of our food supplements are FREE OF pork gelatin.




Chantal Hombourger, Galenic Development Director Arkopharma Laboratories
Extract from an article in the IADN HS Letter of April 2019.